Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2009.133298v1, 2009; 10.1373/clinchem.2009.133298
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Oca, F.
Right arrow Articles by Muller, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oca, F.
Right arrow Articles by Muller, F.

Received on ,
Accepted on ,

Brief Communications

Amniotic Fluid Digestive Enzyme Analysis Is Useful for Identifying CFTR Gene Mutations of Unclear Significance

Florine Oca 1, Sophie Dreux 1, Bénédicte Gérard 2, Brigitte Simon-Bouy 3, Alix de Becdelièvre 4, Claude Ferec 5, Emmanuelle Girodon 4, Françoise Muller 6*

1 Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, France
2 Biochimie Génétique, Hôpital Robert Debré, AP-HP, Paris, France
3 SESEP, Hôpital André Mignot, Le Chesnay, France
4 Biochimie Génétique, CHU Henri Mondor, AP-HP, and INSERM U955 équipe 11, Créteil, France
5 Génétique, CHU Brest, Brest, France
6 Biochimie-Hormonologie, Hôpital Robert Debré, AP-HP, Paris, France, and Université Paris Ile de France Ouest, Paris, France

* To whom correspondence should be addressed. E-mail: francoise.muller{at}rdb.aphp.fr.

BACKGROUND: The large number of CFTR [cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)] mutations and the existence of variants of unclear significance complicate the prenatal diagnosis of cystic fibrosis (CF). The aim of this study was to determine whether the pattern of amniotic fluid digestive enzymes (AF-DEs) could be correlated with the severity of CFTR mutations.

METHODS: The AF-DE pattern ({gamma}-glutamyltranspeptidase, aminopeptidase M, and the intestinal isoform of alkaline phosphatase) was retrospectively analyzed in 43 AF samples. All fetuses presented 2 CFTR mutations, which were classified according to the severity of the disease: CF/CF (n = 38); CF/CFTR-related disorders (n = 1); and CF/unknown variant (n = 4). The relationships between clinical CF status, CFTR mutations, and AF-DE pattern were studied.

RESULTS: Of 38 severely affected CF fetuses, an "obstructive" AF-DE pattern was observed in 15 of 15 samples collected before 22 weeks, irrespective of the CFTR mutation (diagnostic sensitivity, 100%; diagnostic specificity, 99.8%). In the 23 fetuses evaluated after 22 weeks, the AF-DE pattern was abnormal in 7 cases and noncontributive in 16 (diagnostic sensitivity, 30.4%; diagnostic specificity, 99.8%). Of the 5 questionable cases (F508del/N1224K, F508del/L73F, 3849+10kbC>T/G1127E, F508del/S1235R, F508del/G622D), all were CF symptom free at 2–4 years of follow-up. The AF-DE pattern (<22 weeks) was typical in 3 cases but abnormal in the last 2 cases.

CONCLUSIONS: AF-DE analysis is of value for prenatal CF diagnosis in classic forms of CF and could be helpful in nonclassic CF.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Association for Clinical Chemistry.